These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8767527

  • 1. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
    Morabito F, Stelitano C, Callea I, Filangeri M, Oliva B, Sculli G, Callea V, Nobile F, Brugiatelli M.
    Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F, Filangeri M, Callea I, Sculli G, Callea V, Fracchiolla NS, Neri A, Brugiatelli M.
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [Abstract] [Full Text] [Related]

  • 3. The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia.
    Morabito F, Callea I, Console G, Stelitano C, Sculli G, Filangeri M, Oliva B, Musolino C, Iacopino P, Brugiatelli M.
    Haematologica; 1997; 82(5):560-5. PubMed ID: 9407721
    [Abstract] [Full Text] [Related]

  • 4. Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia.
    Morabito F, Callea I, Rodinò A, Messina G, Callea V, Iacopino P, Nobile F, Brugiatelli M.
    Leukemia; 1995 Sep; 9(9):1450-5. PubMed ID: 7658711
    [Abstract] [Full Text] [Related]

  • 5. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V, Molica S, Capalbo S, Pogliani E, Battista C, Broccia G, Montillo M, Cuneo A, Leoni P, Specchia G, Castoldi G.
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [Abstract] [Full Text] [Related]

  • 6. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
    Begleiter A, Verburg L, Ashique A, Lee K, Israels LG, Mowat MR, Johnston JB.
    Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
    [Abstract] [Full Text] [Related]

  • 7. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
    Begleiter A, Wang H, Verburg L, Lee K, Israels LG, Mowat MR, Johnston JB.
    Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
    [Abstract] [Full Text] [Related]

  • 8. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C, Hiddemann W.
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [Abstract] [Full Text] [Related]

  • 9. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [Abstract] [Full Text] [Related]

  • 10. Chlorambucil synergizes with purine analogs in inducing in vitro cytotoxicity in B-cell chronic lymphocytic leukemia.
    Callea I, Console G, Sculli G, Filangeri M, Messina G, Morabito F.
    Haematologica; 1998 Aug; 83(8):756-7. PubMed ID: 9793266
    [Abstract] [Full Text] [Related]

  • 11. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
    Bergmann L.
    Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
    [Abstract] [Full Text] [Related]

  • 12. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
    Stelitano C, Morabito F, Kropp MG, Callea V, Iuliano F, Oriana V, Levato D, Nobile F, Molica S, Brugiatelli M.
    Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
    [Abstract] [Full Text] [Related]

  • 13. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
    Robak T.
    Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM, Katato K, Almatchy VP, Wall N, Liu KZ, Schultz CP, Mantsch HH, Varterasian M, al-Katib AM.
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A, Smolewski P, Najder M, Robak T.
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [Abstract] [Full Text] [Related]

  • 17. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
    Christodoulopoulos G, Malapetsa A, Schipper H, Golub E, Radding C, Panasci LC.
    Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
    [Abstract] [Full Text] [Related]

  • 18. In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.
    Duechler M, Linke A, Cebula B, Shehata M, Schwarzmeier JD, Robak T, Smolewski P.
    Eur J Haematol; 2005 May; 74(5):407-17. PubMed ID: 15813915
    [Abstract] [Full Text] [Related]

  • 19. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J, Koski T, Vilpo L.
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [Abstract] [Full Text] [Related]

  • 20. Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report.
    Ahmad I, Al-Katib AM, Beck FW, Mohammad RM.
    Clin Cancer Res; 2000 Apr; 6(4):1328-32. PubMed ID: 10778958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.